Alfredo Bustamante, Product Manager, commented, The FDA clearance of the S12X Cortical Stimulator and ESAx Electrode Switch Array marks a major advancement for Grass Technologies in the area of Epilepsy Monitoring and Surgery. The advanced products allow the latest technology to assist in crucial brain resection procedures. The market was in dire need for such a product that helps eliminate errors in these critical procedures. Features of the new product include touch-screen stimulator control, touch-screen electrode selection for stimulation, and integrated EEG amplifier connections. These new products will truly make Grass Technologies unique in the field of Diagnostic Epilepsy Monitoring.

Grass Technologies will sell these products for use in conjunction with their long-term Epilepsy Monitoring systems.